A comprehensive study of QOL and fatigue in patients with AML (AML QOL Fatigue)
This 3-year, prospective, longitudinal multi-site cohort study will examine QOL and fatigue at multiple time points over 12 months from diagnosis of AML, and will explore relationships between QOL and fatigue and their relationship with anaemia, depression, fitness, and cytokine levels.
See Trial Summary.
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the Canadian Cancer Society
